Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Feb 5, 2020 at 1:20 PM EST

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin…

Chris Lange | Jan 28, 2020 at 10:40 AM EST

How Far Will Pfizer Stock Slump?

Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.

Chris Lange | Jan 28, 2020 at 9:35 AM EST

Short Sellers Can’t Make Up Their Mind on Big Pharma

The January 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Jan 28, 2020 at 7:05 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Pfizer and Intel above all other Dow stocks.

Chris Lange | Jan 27, 2020 at 11:30 AM EST

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

These three health care companies included are expected to report their earnings on Tuesday morning.

Chris Lange | Jan 26, 2020 at 7:05 AM EST

Half the Dow Reports This Week: Apple, Exxon, Pfizer and More

24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this…

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Jan 13, 2020 at 6:45 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.

Jon C. Ogg | Jan 11, 2020 at 7:05 AM EST

20 Biopharma Stocks for Huge Upside Potential in 2020

Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.

Jon C. Ogg | Jan 7, 2020 at 2:58 PM EST

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.

Jon C. Ogg | Jan 6, 2020 at 12:45 PM EST

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline…

Jon C. Ogg | Jan 2, 2020 at 4:51 PM EST

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better…

Chris Lange | Jan 2, 2020 at 10:25 AM EST

The Top Biopharma Events to Watch in 2020

Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch…

Paul Ausick | Dec 31, 2019 at 6:55 AM EST

5 Top (and Bottom) Dow Performers in 2019

Here's a look at the five best- and five worst-performing stocks among the Dow Jones industrial average this past year.

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 22 23 24 25 26 … 98

Pfizer : PFE

All Pfizer Articles

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

How Far Will Pfizer Stock Slump?

Short Sellers Can’t Make Up Their Mind on Big Pharma

The 5 Most Shorted Dow Stocks

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Half the Dow Reports This Week: Apple, Exxon, Pfizer and More

Short Sellers Shy Away From Big Pharma

The 5 Most Shorted Dow Stocks

20 Biopharma Stocks for Huge Upside Potential in 2020

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

5 Top (and Bottom) Dow Performers in 2019

Big Pharma Short Sellers Get Selective

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Pfizer : PFE

All Pfizer Articles

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

How Far Will Pfizer Stock Slump?

Short Sellers Can’t Make Up Their Mind on Big Pharma

The 5 Most Shorted Dow Stocks

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Half the Dow Reports This Week: Apple, Exxon, Pfizer and More

Short Sellers Shy Away From Big Pharma

The 5 Most Shorted Dow Stocks

20 Biopharma Stocks for Huge Upside Potential in 2020

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

5 Top (and Bottom) Dow Performers in 2019

Big Pharma Short Sellers Get Selective

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%